Clinical Trial Update: A Phase 1 Study of CG009301 for Injection in Adult Subjects With Recurrent or Refractory Haematological Malignancies [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating CG009301 for injection in adults with recurrent or refractory hematologic malignancies; recruitment is ongoing for conditions includi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Leukemia
• Myelodysplastic Syndrome

Drugs mentioned

• CG009301

Snippet

Sponsor: Cullgen (Shanghai),Inc | Conditions: Leukemia, AML | Phase 1 | Status: RECRUITING